Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Type
6.1 Saddle Block Anesthesia
6.2 Peripheral Nerve Block
6.3 Local Anesthesia
6.4 IV Regional Anesthesia
6.5 Interscalene block
6.6 Spinal Anesthesia
6.7 General Anesthesia
Chapter 7 Market Segmentation, By Routes of Administration
7.1 Injection
7.2 Inhalation
Chapter 8 Market Segmentation, By Geography
8.1 North America
8.1.1 Introduction
8.1.2 United States
8.1.3 Canada
8.1.4 Mexico
8.1.5 Others
8.2 Europe
8.2.1 Introduction
8.2.2 U.K
8.2.3 Spain
8.2.4 Italy
8.2.5 France
8.2.6 Russia
8.2.7 Others
8.3 Asia-Pacific
8.3.1 Introduction
8.3.2 China
8.3.3 India
8.3.4 Japan
8.3.5 Australia
8.3.6 Others
8.4 South America
8.4.1 Introduction
8.4.2 Brazil
8.4.3 Argentina
8.4.4 Others
8.5 The Middle East & Africa
8.5.1 Introduction
8.5.2 South Africa
8.5.3 Others
Chapter 9 Competitive Landscape
9.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
9.2 Market Share Analysis
9.3 Strategies Adopted By Top Companies
Chapter 10 Company Profiles
10.1. Boehringer Ingelheim
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiative
10.2. Pfizer
10.3. Novartis
10.4. Roche
10.5. AstraZeneca
10.6. Piramal
10.7. Abbott
10.8. Hospira
10.9. Baxter
10.10. AbbVie
10.11. Aspen
10.12. B. Braun
10.13. Fresenius Kabi
10.14. Hikma Pharmaceuticals PLC
10.15. Mylan N.V.
Chapter 11 Market Estimates and Forecast
11.1 Market Estimates and Forecast 2018-2024(USD Million)
11.1.1 Market Estimation and Forecast by Type 2018-2024 (USD Million)
11.1.2 Market Estimation and Forecast by Routes of Administration 2018-2024 (USD Million)
11.1.3 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 12 Market Insights
12.1 Insights of Industry Experts
12.2 Analyst Opinion (Market Understanding)
12.3 Investment Opportunities
Chapter 13 Appendix
13.1 List of Tables
13.2 List of Figures
